1Maestro B, Molero S, Bajo S, et al. Transcriptional activation of the, hu- man insulin receptor gene by 1,25-dihydioxyvitam in (3)[J].Cell Bio- ehem Func1,2002,20(3 ) :227-232. 被引量：1
2Maestro B, Davila N, Carranza MC, et al. Identification of a vitamin D response element in the human insulin reeeptor gene promoter [J].J Steroid Bioehem Mol Bio1,2003,84 ( 23 ) :223-230. 被引量：1
7Luquet S, GaudeI C, Hoist D, et al. Roles of PPAR delta in lipid absorp- tion and metabolism: a new target for the treatment of type 2 diabeles[ J ]. Bioehim Biophys Acta, 2005,1740 ( 2 ) :313-317. 被引量：1
8Dunlop TW, Vaisanen S, Frank C, et al. The human peroxisome prolifer ator-activated receptor delta gene is a primary target of lalpha,25-dihyd ioxyvitam in D3 and its nuclear receptor[J]. J Mol Biol,2005,349 (2) 248 -260. 被引量：1
9Pittas AG, l,au J, Hu F, et al. The role of in vitam D and calcium in type 2 diabetes. A systematic review and meta-a-nalysis[ J ]. J Clin Endocri- nol Metab, 2007,92 ( 6 ) :2017-2029. 被引量：1
10Draznin B, Sussman K,Kao M, el al. The existence of an optimal range of cytosolic free calcium for insulin stimulated glucose transport in rat adipocytes[ J]. J Biol Chem, 1987,262(30) :14385-14388. 被引量：1
6Dawson Hughes B, Heaney R P, Holick M F,et al. Estimates of optimal vitamin D status [ J ]. Osteoporos Int, 2005,16 (7) :713-716. 被引量：1
7Ishii H,Suzuki H, Baba T, et al. Seasonal variation of glycemic control in type 2 diabetic patients [ J ]. Diabetes Care, 2001,24( 8 ) : 1503-1507. 被引量：1
8Baynes K C, Boucher B J, Feskens E J,et al. Vitamin D,glucose tolerance and insulinaemia in elderly men[ J]. Diabetologia, 1997,40( 3 ) :344-347. 被引量：1
9Chiu K C, Chu A, Go V L, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction [ J]. Am J Clin Nutr,2004,79(5 ) :820-825. 被引量：1
10Scragg R,Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes,and ethnicity in the Third National Health and Nutrition Examination Survey [ J ]. Diabetes Care, 2004, 27 ( 12 ) : 2813- 2818. 被引量：1
2Gaman SA, Balakhonova TV, Sinitsyn VE, et al. Structural and func- tional changes of coronary and carotid arteries in patients with ischemic heart disease [J] . Ter Arkh, 2005, 77 (4) : 15 -21. 被引量：1
3Watts NB, Lewiecki EM, Miller PD, et al. National osteoporosis founda- tion 2008 clinician's guide to prevention and treatment of osteoporosis and the world health organization fracture risk assessment tool (FRAX) : what they mean to the bone densitometrist and bone technologist [ J ] . J Clin Densitom, 2008, 11 (4) : 473 -477. 被引量：1
4Viskari H, Kondrashova A, Koskela P, et al. Circulating vitamin D con- centrations in two neighboring populations with markedly different inci- dence of type 1 diabetesl [J] . Diabetes Care, 2006, 29 (6) : 1458 - 1459. 被引量：1
5Botella - Carretero JI, Alvarez - Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity [J] . Clin Nutr, 2007, 26 (5): 573-580. 被引量：1
6Keman WN, Inzucchi SE, Viscili CM, et al. Insulinresistance and risk for stroke [J] . Neurology, 2002, 59 (6): 809-815. 被引量：1
7Abraham WT. Preventing cardiovascular events in patients with diabetes mellitus [J] . Am J Med, 2004, 116 (Supp15A) : 39 -46. 被引量：1
8Lips P. Worldwide status of vitamin D nutrition [J] . J Steroid Biochem Mol Biol, 2010, 121 (1/2): 297-300. 被引量：1
9Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25 - hydroxyvi- tamin D levels and risk of incident hypertension [ J ]. Hypertension, 2007, 49 (5) : 1063 -1069. 被引量：1
10Lu L, Yu Z, Pan A, et al. Plasma 25 - hydroxyvitamin D concentration and metabolic syndrome among middle - aged and elderly Chinese indi- viduals [J]. Diabetes Care, 2009, 32 (7): 1278-1283. 被引量：1
